Good Steward Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$299K Sell
325
-27
-8% -$27.4K 0.19% 46
2025
Q4
$378K Sell
352
-18
-5% -$17.2K 0.25% 39
2025
Q3
$282K Sell
370
-141
-28% -$105K 0.2% 63
2025
Q2
$398K Sell
511
-69
-12% -$53.6K 0.31% 50
2025
Q1
$479K Buy
+580
New +$483K 0.44% 58

Other funds holding LLY

Good Steward Wealth Advisors's LLY Position: Q1 2026 in Review

Good Steward Wealth Advisors reduced its Eli Lilly (LLY) stake by 7.7% in Q1 2026, selling an estimated $27.4K and leaving 325 shares worth $299K. The position accounts for 0.19% of the portfolio, ranked #46.

Good Steward Wealth Advisors first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $479K in Q1 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Good Steward Wealth Advisors held 325 shares of Eli Lilly worth $299K as of Q1 2026.
  • Good Steward Wealth Advisors sold 27 Eli Lilly shares in Q1 2026, an estimated $27.4K.
  • Eli Lilly made up 0.19% of Good Steward Wealth Advisors's portfolio in Q1 2026, its #46 holding.
  • Good Steward Wealth Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
  • Good Steward Wealth Advisors's Eli Lilly position peaked at $479K in Q1 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Good Steward Wealth Advisors's 13F filing for Q1 2026, filed 4 May 2026.